Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Seeks Withdrawal Of Injectable Bacitracin Despite Extensive Off-Label Use
Jan 31 2020
•
By
Sue Sutter
US FDA has asked ANDA sponsors to stop selling injectable bacitracin. • Source: Shutterstock
More from Drug Safety
More from Pink Sheet